These 9 biotech stocks have doubled this year and are set to double again, analysts say
The bio tech stocks have on average risen by 188% this year and have a median upside potential of 150%.
Source link
- Barclays names UK ‘conviction stock ideas’ for the fourth quarter — giving two over 35% upside
- India made ‘horrific mistake’ by perpetrating secret operations on Canadian territory: Trudeau
